D-0528-2023 Class III Terminated
FDA drug recall D-0528-2023 was initiated by Accord Healthcare, Inc. on Mar 29, 2023 and is designated Class III. Reason for recall: Sub-potent drug: assay test result below specifications at 9-month timepoint. The recall status is terminated (terminated Mar 19, 2025). Affected quantity: 4574 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 12, 2023
- Initiation Date
- Mar 29, 2023
- Termination Date
- Mar 19, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4574 cartons
Product description
Dodex Injectable Cyanocobalamin Injection, USP 1,000 mcg/mL, 25 x1 ML Multiple dose vials, For Intramuscular or Subcutaneous Use Only, Rx Only, Sterile, Manufactured by: Intas Pharmaceuticals Limited Pharmaz Ahnedabad 382 213, INDIA, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703, NDC 16729-533-08.
Reason for recall
Sub-potent drug: assay test result below specifications at 9-month timepoint.
Distribution pattern
Nationwide in the USA.
Code information
Lot #: R2200394 Exp. 03/2024
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0528-2023
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026